170 related articles for article (PubMed ID: 15711127)
1. The microtubule stabilizing agent discodermolide is a potent inducer of accelerated cell senescence.
Klein LE; Freeze BS; Smith AB; Horwitz SB
Cell Cycle; 2005 Mar; 4(3):501-7. PubMed ID: 15711127
[TBL] [Abstract][Full Text] [Related]
2. Resistance to discodermolide, a microtubule-stabilizing agent and senescence inducer, is 4E-BP1-dependent.
Chao SK; Lin J; Brouwer-Visser J; Smith AB; Horwitz SB; McDaid HM
Proc Natl Acad Sci U S A; 2011 Jan; 108(1):391-6. PubMed ID: 21173253
[TBL] [Abstract][Full Text] [Related]
3. Suppression of microtubule dynamics by discodermolide by a novel mechanism is associated with mitotic arrest and inhibition of tumor cell proliferation.
Honore S; Kamath K; Braguer D; Wilson L; Briand C; Jordan MA
Mol Cancer Ther; 2003 Dec; 2(12):1303-11. PubMed ID: 14707271
[TBL] [Abstract][Full Text] [Related]
4. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
5. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
6. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
7. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
8. Distinct pose of discodermolide in taxol binding pocket drives a complementary mode of microtubule stabilization.
Khrapunovich-Baine M; Menon V; Verdier-Pinard P; Smith AB; Angeletti RH; Fiser A; Horwitz SB; Xiao H
Biochemistry; 2009 Dec; 48(49):11664-77. PubMed ID: 19863156
[TBL] [Abstract][Full Text] [Related]
9. The relationship between Taxol and (+)-discodermolide: synthetic analogs and modeling studies.
Martello LA; LaMarche MJ; He L; Beauchamp TJ; Smith AB; Horwitz SB
Chem Biol; 2001 Sep; 8(9):843-55. PubMed ID: 11564553
[TBL] [Abstract][Full Text] [Related]
10. Induction of accelerated senescence by the microtubule-stabilizing agent peloruside A.
Chan A; Gilfillan C; Templeton N; Paterson I; Northcote PT; Miller JH
Invest New Drugs; 2017 Dec; 35(6):706-717. PubMed ID: 28733703
[TBL] [Abstract][Full Text] [Related]
11. A photoaffinity analogue of discodermolide specifically labels a peptide in beta-tubulin.
Xia S; Kenesky CS; Rucker PV; Smith AB; Orr GA; Horwitz SB
Biochemistry; 2006 Oct; 45(39):11762-75. PubMed ID: 17002277
[TBL] [Abstract][Full Text] [Related]
12. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
[TBL] [Abstract][Full Text] [Related]
13. Improved Dose-Response Relationship of (+)-Discodermolide-Taxol Hybrid Congeners.
Nadaradjane C; Yang CH; Rodriguez-Gabin A; Ye K; Sugasawa K; Atasoylu O; Smith AB; Horwitz SB; McDaid HM
J Nat Prod; 2018 Mar; 81(3):607-615. PubMed ID: 29522336
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity.
Isbrucker RA; Gunasekera SP; Longley RE
Cancer Chemother Pharmacol; 2001 Jul; 48(1):29-36. PubMed ID: 11488521
[TBL] [Abstract][Full Text] [Related]
15. (+)-Discodermolide binds to microtubules in stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest.
Hung DT; Chen J; Schreiber SL
Chem Biol; 1996 Apr; 3(4):287-93. PubMed ID: 8807856
[TBL] [Abstract][Full Text] [Related]
16. Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach.
Canales A; Rodríguez-Salarichs J; Trigili C; Nieto L; Coderch C; Andreu JM; Paterson I; Jiménez-Barbero J; Díaz JF
ACS Chem Biol; 2011 Aug; 6(8):789-99. PubMed ID: 21539341
[TBL] [Abstract][Full Text] [Related]
17. Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.
Chen JG; Horwitz SB
Cancer Res; 2002 Apr; 62(7):1935-8. PubMed ID: 11929805
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
19. Total synthesis of the potent microtubule-stabilizing agent (+)-discodermolide.
Harried SS; Lee CP; Yang G; Lee TI; Myles DC
J Org Chem; 2003 Aug; 68(17):6646-60. PubMed ID: 12919029
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of a potent hybrid of the anticancer natural products dictyostatin and discodermolide.
Paterson I; Naylor GJ; Wright AE
Chem Commun (Camb); 2008 Oct; (38):4628-30. PubMed ID: 18815706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]